Page last updated: 2024-10-27

fluoxetine and Body Dysmorphic Disorders

fluoxetine has been researched along with Body Dysmorphic Disorders in 4 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Body Dysmorphic Disorders: Preoccupations with appearance or self-image causing significant distress or impairment in important areas of functioning.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gruber, M1
Jahn, R1
Stolba, K1
Ossege, M1
Krooks, JA1
Weatherall, AG1
Holland, PJ1
Diniz, JB1
Costa, DL1
Cassab, RC1
Pereira, CA1
Miguel, EC1
Shavitt, RG1
Didie, ER1
Kuniega-Pietrzak, T1
Phillips, KA1

Reviews

1 review available for fluoxetine and Body Dysmorphic Disorders

ArticleYear
Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease.
    The Journal of dermatological treatment, 2018, Volume: 29, Issue:4

    Topics: Antipsychotic Agents; Body Dysmorphic Disorders; Cognitive Behavioral Therapy; Fluoxetine; Humans; M

2018

Trials

1 trial available for fluoxetine and Body Dysmorphic Disorders

ArticleYear
The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
    Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Age

2014

Other Studies

2 other studies available for fluoxetine and Body Dysmorphic Disorders

ArticleYear
['Barbie Doll Syndrome'. A case report of body dysmorphic disorder].
    Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2018, Volume: 32, Issue:1

    Topics: Adult; Beauty; Body Dysmorphic Disorders; Body Size; Bulimia Nervosa; Combined Modality Therapy; Dia

2018
Body image in patients with body dysmorphic disorder: evaluations of and investment in appearance, health/illness, and fitness.
    Body image, 2010, Volume: 7, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Attitude to Health; Beauty; Body Dysmorphic Disorde

2010